Back to Trades
Total Value
$50.4K
Net $50.4K sold
Filing Date
Oct 28, 2025
2 transactions
Sales
$50.4K
2 transactions
Trade Summary
On Oct 24, 2025 through Oct 27, 2025, Szot Matthew K, Chief Financial Officer, sold $50.4K of Cadrenal Therapeutics, Inc. (CVKD) across 2 transactions. The filing covers Common Stock and reflects net selling of $50.4K. Reported prices ranged from $13.99. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Cadrenal Therapeutics, Inc.
- Ticker Symbol
- CVKD
- CIK
- 0001937993
Insider Information
- Name
- Szot Matthew K
- Role
- Chief Financial Officer
- Location
- PONTE VEDRA,, FL
Filing Details
- Filing Date
- Oct 28, 2025
- Transaction Date
- Oct 24, 2025
- Accession Number
- 0001213900-25-103147
- Form Type
- 4
- Net Trading Amount
- -$50.4K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Oct 24, 2025 | Common Stock | 1,800 | $13.99 | Sale | $25.2K |
| Oct 27, 2025 | Common Stock | 1,800 | $13.99 | Sale | $25.2K |
Want live alerts when Szot Matthew K trades again?
Download Insider Trades to track CVKD, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on May 9, 2025.